Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This agent is a **combination dietary supplement** containing **eicosapentaenoic acid** (EPA), **gamma-linolenic acid** (GLA), various **vitamins**, and **minerals**. EPA is an omega-3 fatty acid known primarily for its ability to reduce triglyceride levels, prevent excessive blood clotting, and exert anti-inflammatory effects. GLA is an omega-6 fatty acid that serves as a precursor to prostaglandin E1 (PGE1), which has anti-inflammatory, antithrombotic, and lipid-lowering properties. The combination of EPA and GLA is utilized to synergistically modulate the production of pro-inflammatory lipid mediators (eicosanoids); EPA helps counteract the potential accumulation of pro-inflammatory arachidonic acid metabolites produced as a result of GLA supplementation. Supplementation with both EPA and GLA has been studied to help manage chronic inflammatory disorders, cardiovascular health, and potentially bone metabolism. When delivered together with vitamins and minerals, this combination is used as a dietary supplement for supporting general health, though it may also be found formulated for more specific health purposes such as managing dry eye or providing anti-inflammatory support[1][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on eicosapentaenoic acid + gamma-linolenic acid + vitamins + minerals.